Mixed anxiety-depression and its implications far models of mood and anxiety disorders

被引:52
|
作者
Barlow, DH [1 ]
Campbell, LA [1 ]
机构
[1] Boston Univ, Ctr Anxiety & Related Disorders, Boston, MA 02215 USA
关键词
D O I
10.1016/S0010-440X(00)80009-7
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Recent findings have suggested that there is a distinct group of patients presenting with subthreshold levels of mixed anxious and depressive symptoms associated with significant functional impairment. Accumulating evidence of this type ultimately led to a multisite field trial which investigated the possibility of developing a new category of mixed anxiety-depression (MAD) for the DSM-IV, The field trial confirmed both the existence and impairment of a sizable group of patients with mixed subclinical anxious and depressive symptoms, and provisional criteria for MAD were proposed. Although the validity of the tentative MAD category has yet to be established, the unique characteristics of patients presenting with MAD symptoms have important implications for models of mood and anxiety disorders. We argue that the particular pattern of impairment associated with MAD provides additional evidence that anxiety and depressive disorders have a shared diathesis best captured by the construct of nonspecific negative affect. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 50 条
  • [41] An open-label pilot study of fluvoxamine for mixed anxiety-depression
    Houck, C
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (02) : 225 - 227
  • [42] Treatment of mixed anxiety-depression disorder:: Long-term outcome
    Echeburúa, E
    Salaberría, K
    de Corral, P
    Cenea, R
    [J]. BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2006, 34 (01) : 95 - 101
  • [43] RELATIONSHIP BETWEEN ANXIETY-DEPRESSION AND NEUROSES
    FOULDS, GA
    BEDFORD, A
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1976, 128 (FEB) : 166 - 168
  • [44] The multi-central clinical study on the efficacy of paroxetine over anxiety symptoms in mixed anxiety-depression
    Kocabasoglu, N
    Corapcioglu, A
    Yargic, I
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S213 - S214
  • [45] Tandospirone in the treatment of generalised anxiety disorder and mixed anxiety-depression - Results of a comparatively high dosage trial
    Nishitsuji, K
    To, H
    Murakami, Y
    Kodama, K
    Kobayashi, D
    Yamada, T
    Kubo, C
    Mine, K
    [J]. CLINICAL DRUG INVESTIGATION, 2004, 24 (02) : 121 - 126
  • [46] Clinical Study on Electroacupuncture for Post-withdrawal Anxiety-depression Mood in Heroin Addicts
    穆敬平
    刘莉
    程建明
    周立志
    敖金波
    王军
    方伟
    胡军
    韩丑萍
    [J]. Journal of Acupuncture and Tuina Science, 2009, 7 (04) : 203 - 206
  • [47] Clinical study on electroacupuncture for post-withdrawal anxiety-depression mood in heroin addicts
    Mu J.-P.
    Liu L.
    Cheng J.-M.
    Zhou L.-Z.
    Ao J.-B.
    Wang J.
    Fang W.
    Hu J.
    [J]. Journal of Acupuncture and Tuina Science, 2009, 7 (4) : 203 - 206
  • [48] Serotonergic dysfunction - implications for treatment of mood and anxiety disorders
    Blier, P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S706 - S706
  • [49] Efficacy of Silexan in mixed anxiety-depression - A randomized, placebo-controlled trial
    Kasper, Siegfried
    Volz, Hans-Peter
    Dienel, Angelika
    Schlaefke, Sandra
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (02) : 331 - 340
  • [50] CLORAZEPAT IN THE TREATMENT OF ANXIETY-DEPRESSION SYNDROMES IN NEUROSES
    FLORKOWSKI, A
    KOCUR, J
    RYDZYNSKI, Z
    DUSZYK, S
    TRENDAK, W
    GRUSZCZYNSKI, W
    [J]. ACTIVITAS NERVOSA SUPERIOR, 1989, 31 (01): : 26 - 27